We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A Phase I/II Study Comparing Regimen Schedules of Gemcitabine and Docetaxel in Japanese Patients with Stage IIIB/IV Non-small Cell Lung Cancer.
- Authors
Matsui, Kaoru; Hirashima, Tomonori; Nitta, Takashi; Kobayashi, Masashi; Ogata, Yoshitaka; Furukawa, Mitsugi; Kudoh, Shinzoh; Yoshimura, Naruo; Mukohara, Toru; Yamauchi, Setsuko; Shiraishi, Satoshi; Kamoi, Hiroshi; Negoro, Syunichi; Takeda, Kouji; Nakagawa, Kazuhiko; Takada, Minoru; Yana, Takashi; Fukuoka, Masahiro
- Abstract
Objective: Gemcitabine and docetaxel are non-platinum agents with activity in non-small cell lung cancer (NSCLC). This study was conducted to determine and evaluate the recommended regimen of gemcitabine–docetaxel and evaluated its efficacy and safety in chemonaive Japanese NSCLC patients.
- Publication
Japanese Journal of Clinical Oncology, 2005, Vol 35, Issue 4, p181
- ISSN
0368-2811
- Publication type
Article
- DOI
10.1093/jjco/hyi057